{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:21:42Z","timestamp":1784614902815,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115549","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:56:28Z","timestamp":1687812988000},"page":"115549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Experimental validation for mechanisms of Qizhiweitong particles against Chronic Non-atrophic gastritis based on metabolomics and network pharmacology"],"prefix":"10.1016","volume":"234","author":[{"given":"Jianxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linliu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuocheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengye","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3253-0706","authenticated-orcid":false,"given":"Huijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2023.115549_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1751-2980.12593","article-title":"Chinese Society of Gastroenterology, Chinese Medical Association, Chinese consensus on chronic gastritis (2017, Shanghai)","volume":"19","author":"Fang","year":"2018","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.jpba.2023.115549_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-14-21","article-title":"Chronic gastritis in China: a national multi-center survey","volume":"14","author":"Du","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijc.11680","article-title":"Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer","volume":"109","author":"Ohata","year":"2004","journal-title":"Int J. Cancer"},{"issue":"18","key":"10.1016\/j.jpba.2023.115549_bib4","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1517\/14656566.2012.747510","article-title":"Current pharmacotherapy options for gastritis","volume":"13","author":"den Hollander","year":"2012","journal-title":"Expert Opin. Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2023.115549_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jpba.2023.115549_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/17512433.2018.1531703","article-title":"Proton pump inhibitors: use and misuse in the clinical setting","volume":"11","author":"Savarino","year":"2018","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"8","key":"10.1016\/j.jpba.2023.115549_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jpba.2023.115549_bib8","article-title":"The efficacy and safety of Xiangsha Liujunzi decoction in the treatment of chronic non-atrophic gastritis: a protocol for a systematic review and meta-analysis","volume":"100","author":"Yue","year":"2021","journal-title":"Med. (Baltim.)"},{"issue":"12","key":"10.1016\/j.jpba.2023.115549_bib9","first-page":"2430","article-title":"Discussion on mechanism of Qizhi Weitong Granules in treating gastritis based on network pharmacology and experimental verification","volume":"45","author":"Yang","year":"2022","journal-title":"Drug Eval. Res."},{"key":"10.1016\/j.jpba.2023.115549_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jep.2016.05.024","article-title":"Multicomponent, multitarget integrated adjustment - metabolomics study of Qizhiweitong particles curing gastrointestinal motility disorders in mice induced by atropine","volume":"189","author":"Chang","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"01","key":"10.1016\/j.jpba.2023.115549_bib11","first-page":"103","article-title":"To study the spectrum-effect relationship of Qizhiweitong particles treating gastric ulcer","volume":"17","author":"Li","year":"2015","journal-title":"Mod. Tradit. Chin. Med. Mater. Med. -World Sci. Technol."},{"issue":"2","key":"10.1016\/j.jpba.2023.115549_bib12","first-page":"295","article-title":"Studies on activity of effective components in Qizhiweitong granules based on Anti-inflammatory and analgesic effect","volume":"24","author":"Xu","year":"2013","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"10.1016\/j.jpba.2023.115549_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1646905","article-title":"Applications of network pharmacology in traditional Chinese medicine research","volume":"2020","author":"Zhou","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network pharmacology in research of Chinese medicine formula: methodology, application and prospective","volume":"26","author":"Luo","year":"2020","journal-title":"Chin. J. Integr. Med"},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib15","first-page":"1","article-title":"TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches","volume":"19","author":"Wang","year":"2021","journal-title":"Chin. J. Nat. Med."},{"issue":"7","key":"10.1016\/j.jpba.2023.115549_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpba.2023.115549_bib17","article-title":"Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression","volume":"264","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"41","key":"10.1016\/j.jpba.2023.115549_bib18","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1073\/pnas.1516878112","article-title":"Illuminating the dark matter in metabolomics","volume":"112","author":"da Silva","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpba.2023.115549_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.aca.2016.02.001","article-title":"Chemometric methods in data processing of mass spectrometry-based metabolomics: a review","volume":"914","author":"Yi","year":"2016","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11418-017-1144-z","article-title":"Enzyme-linked immunosorbent assay for the quantitative\/qualitative analysis of plant secondary metabolites","volume":"72","author":"Sakamoto","year":"2018","journal-title":"J. Nat. Med."},{"issue":"17","key":"10.1016\/j.jpba.2023.115549_bib21","first-page":"191","article-title":"Rat model of chronic superficial gastritis","volume":"17","author":"Ren","year":"2011","journal-title":"Chang. Univ. Chin. Med."},{"issue":"2","key":"10.1016\/j.jpba.2023.115549_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.jpba.2023.115549_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharm. Ther."},{"issue":"3\u20134","key":"10.1016\/j.jpba.2023.115549_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0090-6980(00)00067-8","article-title":"Eicosanoids and the stomach","volume":"61","author":"Atay","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jpba.2023.115549_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2018.09.047","article-title":"Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets","volume":"171","author":"Rukoyatkina","year":"2018","journal-title":"Thromb. Res"},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.advms.2017.06.004","article-title":"A systematic review on the role of eicosanoid pathways in rheumatoid arthritis","volume":"63","author":"Hoxha","year":"2018","journal-title":"Adv. Med. Sci."},{"issue":"5822","key":"10.1016\/j.jpba.2023.115549_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/292472a0","article-title":"Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa","volume":"292","author":"Whittle","year":"1981","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jpba.2023.115549_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/500984","article-title":"Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation","volume":"193","author":"Li","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib29","doi-asserted-by":"crossref","first-page":"G148","DOI":"10.1152\/ajpgi.00137.2003","article-title":"Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2","volume":"286","author":"Tanigawa","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"10","key":"10.1016\/j.jpba.2023.115549_bib30","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1194\/jlr.R046920","article-title":"Novel lysophosphoplipid receptors: their structure and function","volume":"55","author":"Makide","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib31","first-page":"681","article-title":"A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma","volume":"19","author":"Sun","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jpba.2023.115549_bib32","article-title":"UPLC-Q-TOF\/MS-based serum and urine metabonomics study on the ameliorative effects of palmatine on Helicobacter pylori-induced chronic atrophic gastritis","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.jpba.2023.115549_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jsre.2000.5941","article-title":"Lysophosphatidic acid stimulates intestinal restitution via cytoskeletal activation and remodeling","volume":"92","author":"Hines","year":"2000","journal-title":"J. Surg. Res"},{"issue":"3","key":"10.1016\/j.jpba.2023.115549_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.jbchem.a003101","article-title":"Phospholipase A2","volume":"131","author":"Murakami","year":"2002","journal-title":"J. Biochem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:32:29Z","timestamp":1760002349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"alternative-id":["S0731708523003187"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115549","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental validation for mechanisms of Qizhiweitong particles against Chronic Non-atrophic gastritis based on metabolomics and network pharmacology","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115549"}}